Evidence map›Paper›PMID 22028875›Full record

ArticlePloS one2011

Dynein light chain Tctex-type 1 modulates orexin signaling through its interaction with orexin 1 receptor.

David Duguay, Erika Bélanger-Nelson, Valérie Mongrain, Anna Beben, Armen Khatchadourian, Nicolas Cermakian

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 26 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Mouse models of Down syndrome: gene content and consequences.Mammalian genome : official journal of the International Mammalian Genome Society · 2016
    Review
  6. Article
  7. Review
  8. Orexin/hypocretin receptor signalling cascades.British journal of pharmacology · 2014
    Review
  9. Review
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

David DuguayLaboratory of Molecular Chronobiology, Douglas Mental Health University Institute, Montréal, Quebec, Canada.
Erika Bélanger-Nelson
Valérie Mongrain
Anna Beben
Armen Khatchadourian
Nicolas Cermakian
Douglas Mental Health University Institute · CA

Funding

Canadian Institutes of Health Research MOP-67167Canadian Institutes of Health Research MOP-84441
6 · The paper itself

Abstract

Orexins (OX-A, OX-B) are neuropeptides involved in the regulation of the sleep-wake cycle, feeding and reward, via activation of orexin receptors 1 and 2 (OX1R, OX2R). The loss of orexin peptides or functional OX2R has been shown to cause the sleep disorder, narcolepsy. Since the regulation of orexin receptors remains largely undefined, we searched for novel protein partners of the intracellular tail of orexin receptors. Using a yeast two-hybrid screening strategy in combination with co-immunoprecipitation experiments, we found interactions between OX1R and the dynein light chains Tctex-type 1 and 3 (Dynlt1, Dynlt3). These interactions were mapped to the C-terminal region of the dynein light chains and to specific residues within the last 10 amino acids of OX1R. Hence, we hypothesized that dynein light chains could regulate orexin signaling. In HEK293 cells expressing OX1R, stimulation with OX-A produced a less sustained extracellular signal-regulated kinases 1/2 (ERK1/2) activation when Dynlt1 was co-expressed, while it was prolonged under reduced Dynlt1 expression. The amount of OX1R located at the plasma membrane as well as the kinetics and extent of OX-A-induced internalization of OX1R (disappearance from membrane) were not altered by Dynlt1. However, Dynlt1 reduced the localization of OX1R in early endosomes following initial internalization. Taken together, these data suggest that Dynlt1 modulates orexin signaling by regulating OX1R, namely its intracellular localization following ligand-induced internalization.

Indexed as

Signal TransductionDown-RegulationDyneinsEndosomesEnzyme ActivationHEK293 CellsHumansIntracellular Signaling Peptides and ProteinsLigandsMitogen-Activated Protein Kinase 1Mitogen-Activated Protein Kinase 3Mutagenesis, Site-DirectedMutationNeuropeptidesOrexin ReceptorsOrexinsDyneinsDynlt1b protein, mouseDYNLT3 protein, mouseHCRTR2 protein, humanIntracellular Signaling Peptides and ProteinsLigandsMitogen-Activated Protein Kinase 1Mitogen-Activated Protein Kinase 3NeuropeptidesOrexin ReceptorsOrexinsReceptors, G-Protein-CoupledReceptors, Neuropeptide

Identifiers

PMID22028875
PMCPMC3197643
OpenAlexW2091074069

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.